Publications by authors named "I Borbath"

Claim this Profile
L
Linking Structure to Electrocatalytic Performance: Graphene Nanoplatelets-Derived Novel Mixed Oxide-Carbon Composites as Supports for Pt Electrocatalysts with Enhanced Stability.
Ilgar Ayyubov, Emília Tálas, Irina Borbáth, Zoltán Pászti, László Trif

Nanomaterials (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1.
Jean-Luc Van Laethem, Karen Geboes, Ivan Borbath, Teresa Macarulla Mercade, Aurélien Lambert

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histology.
Laurent Meric de Bellefon, Francesco Natalucci, Adrien Nzeusseu Toukap, Tatiana Sokolova, Christine Galant, Ivan Borbath

Front Med (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to letter comments on: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).
D Malka, I Borbath, A Lopes, T Vandamme, J Edeline

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.
Siddharth Chhajlani, Jelka Kuiper, Philippe Beutels, Ivan Borbath, Wouter Dercksen

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis